|
Professional profile/background:
|
|
I qualified from Charing Cross & Westminster Medical School
in 1992 and trained in Haematology in London and Bristol. In 2005,
I was appointed as Consultant Paediatric Haematologist at Bristol
Royal Hospital for Children. With colleagues, I am
responsible for providing and developing the paediatric tertiary
malignant haematology service for Bristol and the South West, and a
Supra-regional Stem Cell Transplantation service, offering
autologous, allogeneic and cord blood for children with malignant
and non-malignant disorders. I am the Lead for
paediatric Haemoglobinopathy and Red cell disorders for Bristol and
South West and aim to bid to be the Haemoglobinopathy Coordinating
Centre for the region in the new proposed Haemoglobinopathy Service
Commissioning Model. I am Paediatric Lead for Intrathecal
chemotherapy and Transfusion.
Nationally I am the Lead for Paediatric Philadelphia Positive
Acute Lymphoblastic Leukaemia (Ph+ ALL), and UK Chief Investigator
on the current International Ph + ALL study, EsPhALL 2017. I am a
local Principal Investigator in multiple clinical trials and am a
member of the NCRI Childhood Leukaemia Sub-Group. In June
2014 I was appointed as Chair of UK Childhood Leukaemia Clinicians
Network, the key organisation representing all paediatric leukaemia
principal treatment centres in the UK. As part of this role I
have enabled the development of national guidelines and taken part
in stakeholder consultations with the National Institute for Health
and Care Excellence. I have recently been appointed as a clinical
expert on the National CAR-T Clinical Panel (NCCP) for Acute
Lymphoblastic Leukaemia.
|
|
